Charles Hutchinson

Charles Hutchinson

Auto-generated profile, based on publicly available information

Charles Hutchinson

Warwick Medical School, University of Warwick, Coventry, UK

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
JGJames Griffin
James Griffin
EDEdward T Davis
Edward T Davis
HPHelen Parsons
Helen Parsons
EMElke Gemperle Mannion
Elke Gemperle Mannion
CKChetan Khatri
Chetan Khatri
AMAndrew Metcalfe
Andrew Metcalfe
Introduction Robotic-assisted knee replacement systems have been introduced to healthcare services worldwide in an effort to improve clinical outcomes for people, although high-quality evidence that they are clinically, or cost-effective remains sparse. Robotic-arm systems may improve surgical accuracy and could contribute to reduced pain, improved function and lower overall cost of total knee replacement (TKR) surgery. However, TKR with conventional instruments may be just as effective and may be quicker and cheaper. There is a need for a robust evaluation of this technology, including cost-effectiveness analyses using both within-trial and modelling approaches. This trial will compare robotic-assisted against conventional TKR to provide high-quality evidence on whether robotic-assisted knee replacement is beneficial to patients and cost-effective for healthcare systems. Methods and analysis The Robotic Arthroplasty Clinical and cost Effectiveness Randomised controlled trial-Knee is a multicentre, participant-assessor blinded, randomised controlled trial to evaluate the clinical and cost-effectiveness of robotic-assisted TKR compared with TKR using conventional instruments. A total of 332 participants will be randomised (1:1) to provide 90% power for a 12-point difference in the primary outcome measure; the Forgotten Joint Score at 12 months postrandomisation. Allocation concealment will be achieved using computer-based randomisation performed on the day of surgery and methods for blinding will include sham incisions for marker clusters and blinded operation notes. The primary analysis will adhere to the intention-to-treat principle. Results will be reported in line with the Consolidated Standards of Reporting Trials statement. A parallel study will collect data on the learning effects associated with robotic-arm systems. Ethics and dissemination The trial has been approved by an ethics committee for patient participation (East Midlands—Nottingham 2 Research Ethics Committee, 29 July 2020. NRES number: 20/EM/0159). All results from the study will be disseminated using peer-reviewed publications, presentations at international conferences, lay summaries and social media as appropriate. Trial registration number ISRCTN27624068.

1 November 1997 in British Journal of Radiology
Verified
Journal Article
Closed access
JRJ J Rankine
J J Rankine
CHC E Hutchinson
C E Hutchinson
DHD G Hughes
D G Hughes
The aim of this study was to determine whether a single T2 weighted sagittal sequence could replace the conventional three sequence examination of the lumbar spine. The T2 weighted sagittal image of 79 lumbar spine MRI examinations were retrospectively reported by three radiologists. Features relating to degenerative disease were recorded and an assessment made of whether further sequences were likely to add information. On a separate occasion the T1 weighted and T2 weighted sagittal and T2 weighted axial sequences were reported blind in relation to the initial assessment. Areas of disagreement were resolved by consensus opinion. The T2 weighted sequence was compared with the three sequences, taking the three sequence examination as the standard. Disc protrusions were diagnosed from the T2 weighted sagittal images with a sensitivity of 38% and a specificity of 97%. 22 discs reported as a disc bulge on the T2 weighted sequence were re-classified as a disc protrusion on axial images because of their focal nature. Central canal stenosis was diagnosed on the T2 weighted sagittal sequence with a sensitivity of 60% and a specificity of 95%. After assessing the T2 weighted sequence, it was thought unlikely that further sequences would add extra information in 60% of cases (48/79). However, further information was obtained in 21% of these cases (10/48) when all the sequences were assessed. The extra information gained by using all three sequences was considered to be of greater benefit than the time saved by using a single T2 sagittal sequence. Other diagnoses where the additional sequences proved helpful are discussed.

1 February 2022 in Health Technology Assessment
Verified
Journal Article
Closed access
PDF file
DGDamian Griffin
Damian Griffin
EDEdward J Dickenson
Edward J Dickenson
FAFelix Achana
Felix Achana
JGJames Griffin
James Griffin
JSJoanna Smith
Joanna Smith
JDJenny Donovan
Jenny Donovan
Background: Femoroacetabular impingement syndrome is an important cause of hip pain in young adults. It can be treated by arthroscopic hip surgery or with physiotherapist-led conservative care. Objective: To compare the clinical effectiveness and cost-effectiveness of hip arthroscopy with best conservative care. Design: The UK FASHIoN (full trial of arthroscopic surgery for hip impingement compared with non-operative care) trial was a pragmatic, multicentre, randomised controlled trial that was carried out at 23 NHS hospitals. Participants: Participants were included if they had femoroacetabular impingement, were aged ≥ 16 years old, had hip pain with radiographic features of cam or pincer morphology (but no osteoarthritis) and were believed to be likely to benefit from hip arthroscopy. Intervention: Participants were randomly allocated (1 : 1) to receive hip arthroscopy followed by postoperative physiotherapy, or personalised hip therapy (i.e. an individualised physiotherapist-led programme of conservative care). Randomisation was stratified by impingement type and recruiting centre using a central telephone randomisation service. Outcome assessment and analysis were masked. Main outcome measure: The primary outcome was hip-related quality of life, measured by the patient-reported International Hip Outcome Tool (iHOT-33) 12 months after randomisation, and analysed by intention to treat. Results: Between July 2012 and July 2016, 648 eligible patients were identified and 348 participants were recruited. In total, 171 participants were allocated to receive hip arthroscopy and 177 participants were allocated to receive personalised hip therapy. Three further patients were excluded from the trial after randomisation because they did not meet the eligibility criteria. Follow-up at the primary outcome assessment was 92% (N = 319; hip arthroscopy, n = 157; personalised hip therapy, n = 162). At 12 months, mean International Hip Outcome Tool (iHOT-33) score had improved from 39.2 (standard deviation 20.9) points to 58.8 (standard deviation 27.2) points for participants in the hip arthroscopy group, and from 35.6 (standard deviation 18.2) points to 49.7 (standard deviation 25.5) points for participants in personalised hip therapy group. In the primary analysis, the mean difference in International Hip Outcome Tool scores, adjusted for impingement type, sex, baseline International Hip Outcome Tool score and centre, was 6.8 (95% confidence interval 1.7 to 12.0) points in favour of hip arthroscopy (p = 0.0093). This estimate of treatment effect exceeded the minimum clinically important difference (6.1 points). Five (83%) of six serious adverse events in the hip arthroscopy group were related to treatment and one serious adverse event in the personalised hip therapy group was not. Thirty-eight (24%) personalised hip therapy patients chose to have hip arthroscopy between 1 and 3 years after randomisation. Nineteen (12%) hip arthroscopy patients had a revision arthroscopy. Eleven (7%) personalised hip therapy patients and three (2%) hip arthroscopy patients had a hip replacement within 3 years. Limitations: Study participants and treating clinicians were not blinded to the intervention arm. Delays were encountered in participants accessing treatment, particularly surgery. Follow-up lasted for 3 years. Conclusion: Hip arthroscopy and personalised hip therapy both improved hip-related quality of life for patients with femoroacetabular impingement syndrome. Hip arthroscopy led to a greater improvement in quality of life than personalised hip therapy, and this difference was clinically significant at 12 months. This study does not demonstrate cost-effectiveness of hip arthroscopy compared with personalised hip therapy within the first 12 months. Further follow-up will reveal whether or not the clinical benefits of hip arthroscopy are maintained and whether or not it is cost-effective in the long term. Trial registration: Current Controlled Trials ISRCTN64081839. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 26, No. 16. See the NIHR Journals Library website for further project information.

1 November 2023 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
MMMatthew S. Macpherson
Matthew S. Macpherson
CHCharles E. Hutchinson
Charles E. Hutchinson
CHCarolyn Horst
Carolyn Horst
VGVicky Goh
Vicky Goh
Giovanni MontanaGiovanni Montana
Giovanni Montana
To train an explainable deep learning model for patient reidentification in chest radiograph datasets and assess changes in model-perceived patient identity as a marker for emerging radiologic abnormalities in longitudinal image sets. This retrospective study used a set of 1 094 537 frontal chest radiographs and free-text reports from 259 152 patients obtained from six hospitals between 2006 and 2019, with validation on the public ChestX-ray14, CheXpert, and MIMIC-CXR datasets. A deep learning model was trained for patient reidentification and assessed on patient identity confirmation, retrieval of patient images from a database based on a query image, and radiologic abnormality prediction in longitudinal image sets. The representation learned was incorporated into a generative adversarial network, allowing visual explanations of the relevant features. Performance was evaluated with sensitivity, specificity, F1 score, Precision at 1, R-Precision, and area under the receiver operating characteristic curve (AUC) for normal and abnormal prediction. Patient reidentification was achieved with a mean F1 score of 0.996 ± 0.001 (2 SD) on the internal test set (26 152 patients) and F1 scores of 0.947–0.993 on the external test data. Database retrieval yielded a mean Precision at 1 score of 0.976 ± 0.005 at 299 × 299 resolution on the internal test set and Precision at 1 scores between 0.868 and 0.950 on the external datasets. Patient sex, age, weight, and other factors were identified as key model features. The model achieved an AUC of 0.73 ± 0.01 for abnormality prediction versus an AUC of 0.58 ± 0.01 for age prediction error. The image features used by a deep learning patient reidentification model for chest radiographs corresponded to intuitive human-interpretable characteristics, and changes in these identifying features over time may act as markers for an emerging abnormality. Keywords: Conventional Radiography, Thorax, Feature Detection, Supervised Learning, Convolutional Neural Network, Principal Component Analysis Supplemental material is available for this article. © RSNA, 2023 See also the commentary by Raghu and Lu in this issue.

1 March 2021 in The Knee
Verified
Journal Article
Open access
IAImran Ahmed
Imran Ahmed
HMHaseeb Moiz
Haseeb Moiz
WCWilliam Carlos
William Carlos
CEClaire Edwin
Claire Edwin
SSSophie Staniszewska
Sophie Staniszewska
AMAndrew Metcalfe
Andrew Metcalfe
Magnetic resonance imaging (MRI) is one of the most widely used investigations for knee pain as it provides detailed assessment of the bone and soft tissues. The aim of this study is to report the frequency of each diagnosis identified on MRI scans of the knee and explore the relationship between MRI results and onward treatment. Consecutive MRI reports from a large NHS trust performed in 2017 were included in this study. The hospital electronic system was consulted to identify whether a patient underwent x-ray prior to the MRI, attended an outpatient appointment or underwent surgery. 4466 MRI knees were performed in 2017 with 71.2% requested in primary care and 28.1% requested in secondary care. The most common diagnosis was signs of arthritis (55.2%), followed by meniscal tears (42.8%) and ACL tears (8.3%). 49.4% of patients who had an MRI attended outpatients and 15.6% underwent surgery. The rate of knee surgery was significantly higher for patients who had their scans requested in secondary care (32.9% vs 8.9%, p < 0.001). The rate of surgical intervention following MRI is low and given these results it seems unlikely that the scan changes practice in most cases. The rate of surgery and outpatient follow up was significantly higher in scans requested by secondary care. We urge clinicians avoid wasteful use of MRI and recommend the use of plain radiography prior to MRI where arthritis may be present.

1 August 2023 in Efficacy and Mechanism Evaluation
Verified
Journal Article
Open access
PDF file
AMAndrew Metcalfe
Andrew Metcalfe
SASusanne Arnold
Susanne Arnold
HPHelen Parsons
Helen Parsons
NPNick R Parsons
Nick R Parsons
GBGev Bhabra
Gev Bhabra
MUMartin Underwood
Martin Underwood
Background: A balloon spacer is a relatively simple addition to an arthroscopic debridement procedure for irreparable rotator cuff tears. Objective: To evaluate the clinical and cost-effectiveness of a subacromial balloon spacer for individuals undergoing arthroscopic debridement for irreparable rotator cuff tears. Design: A multicentre participant-and assessor-blinded randomised controlled trial comparing arthroscopic debridement with the InSpace® (Stryker, Kalamazoo, MI, USA) balloon to arthroscopic debridement alone, using a novel adaptive design. Pretrial simulations informed stopping boundaries for two interim analyses, using outcome data from early and late time points. Setting: A total of 24 NHS centres. Participants: Adults with a symptomatic, irreparable rotator cuff tear for whom conservative management had been unsuccessful. Interventions: Arthroscopic debridement of the subacromial space plus insertion of the InSpace balloon compared with arthroscopic debridement alone. Main outcome measures: Oxford Shoulder Score at 12 months. Results: A predefined stopping boundary was met at the first interim analysis. Recruitment stopped with 117 participants randomised. We obtained primary outcome data on 114 participants (97%). The mean Oxford Shoulder Score at 12 months was 34.3 in the debridement-only group (59 participants of 61 randomised) and 30.3 in the debridement with balloon group (55 participants of 56 randomised; mean difference: −4.2; 95% confidence interval −8.2 to −0.26; p = 0.037). There was no difference in safety events. In the cost-effectiveness analysis, debridement-only dominated with a probability of <1% that the device is cost-effective. Magnetic resonance imaging substudy: To evaluate the function of the balloon, we developed a dynamic magnetic resonance imaging protocol to induce humeral movement by activating the deltoid. The pandemic restricted recruitment, so the sample size was small (n = 17). Statistical methodology study: We applied the novel adaptive design approach to data from seven previous randomised controlled trials. The method would have been applicable to five of these trials and would have made substantial savings in time to recruitment, without compromising the main findings of the included trials. Interim analysis interpretation study: We asked potential data monitoring committee members to review interim analysis reports presented using Bayesian and frequentist frameworks. They did not always follow the stopping rules and would benefit from additional information to support decision-making. Limitations: The InSpace balloon could be beneficial in a different population although we are not aware of it being widely used for other purposes. As a result of the pandemic, we were not able to complete data collection for objective measures. Conclusions: In this efficient adaptive trial, clinical and cost-effectiveness favoured the control treatment without the InSpace balloon. Therefore, we do not recommend this device for the treatment of irreparable rotator cuff tears. Future work: There is an urgent need for high-quality research into interventions for people with irreparable rotator cuff tears as there is a lack of good evidence for all available treatment options at present. Trial registration: This trial is registered as ISRCTN17825590. Funding: This project (project reference 16/61/18) was funded by the Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council and National Institute for Health and Care Research (NIHR) partnership. The trial is co-sponsored by the University of Warwick and University Hospitals Coventry and Warwickshire NHS Trust. This study will be published in full in Efficacy and Mechanism Evaluation; Vol. 10, No 3. See the NIHR Journals Library website for further project information.